The following was reported via phone call on (b)(6) 2016.Results are as follows: date: (b)(6) 2016, inratio inr: 7.5 and 1.8.Prior week, inratio inr: 0.9.Therapeutic range: 2.0 - 3.0.The time between testing on (b)(6) 2016 was ten (10) minutes.Reportedly, the finger was "milked" after the finger stick, a sufficient blood sample was unable to be obtained and multiple drops of blood was added to the testing strip.These are considered to be improper techniques when performing the inratio test.Additionally, it was possible that the monitor was moved during testing.There was no reported adverse patient sequela and no additional information provided.
|
Investigation/conclusion: as of (b)(6) 2016, the device was not returned for evaluation.Therefore, a review of the testing history for the reported lot was performed.In-house testing on strip lot 370105ar met release criteria and the product performed as expected.The manufacturing records for the lot were reviewed and the lot met release specifications.Although improper techniques were identified in the complaint, the root cause cannot be determined from the information provided by the customer.Based on the information available, there is no indication of a product deficiency and no corrective action is required.
|